Novaremed AG
PrivateLast Round
PIPE
Jan 28, 2021
Company Overview
Novaremed AG is a biopharmaceutical company that develops small bio-molecule drugs for the treatment of neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novaremed AG Comparables
Compare Novaremed AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plumeria Therapeutics, Inc. | 85% | |
| NeuroFront Therapeutics | 84% | |
| 上海赛默罗生物科技有限公司 | 83% |
Novaremed AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| PIPE | Jan 28, 2021 | ||||
| VC Round | Sep 15, 2020 | ||||
| VC Round | Sep 2, 2019 | ||||
| VC Round | Aug 23, 2018 | ||||
| VC Round | Apr 19, 2018 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2021
$50M raised from Gemny.
- Sep 2, 2019
Raised $2.63M in a VC Round.
Novaremed AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Novaremed AG's valuation, stock price, and market status.
Is Novaremed a public or private company?
Novaremed is a private company.
What is the current stock price of Novaremed?
Novaremed is a private company with no public stock price. No recent secondary market data is available.
How much is Novaremed worth (valuation)?
Valuation information for Novaremed is not publicly available.
Can I buy Novaremed stock?
Novaremed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Novaremed's last funding round?
Novaremed's most recent funding round was Private Placement on January 28, 2021.
Who are the main investors in Novaremed?
Investor information for Novaremed is not publicly disclosed.
Will Novaremed IPO soon?
No public IPO plans have been announced for Novaremed.
How can I track Novaremed secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novaremed's secondary market activity and sign up for updates.